These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12685885)

  • 1. Zanamivir: a significant reduction in viral load during treatment in military conscripts with influenza.
    Puhakka T; Lehti H; Vainionpää R; Jormanainen V; Pulkkinen M; Sharp S; Kerr C; Dempsey M; Ring CJ; Ward C; Tisdale M
    Scand J Infect Dis; 2003; 35(1):52-8. PubMed ID: 12685885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.
    Mäkelä MJ; Pauksens K; Rostila T; Fleming DM; Man CY; Keene ON; Webster A
    J Infect; 2000 Jan; 40(1):42-8. PubMed ID: 10762110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM; Gunawardena KA; Macmahon MM; Bye A
    Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.
    Hayden FG; Gubareva LV; Monto AS; Klein TC; Elliot MJ; Hammond JM; Sharp SJ; Ossi MJ;
    N Engl J Med; 2000 Nov; 343(18):1282-9. PubMed ID: 11058672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
    Hayden FG; Osterhaus AD; Treanor JJ; Fleming DM; Aoki FY; Nicholson KG; Bohnen AM; Hirst HM; Keene O; Wightman K
    N Engl J Med; 1997 Sep; 337(13):874-80. PubMed ID: 9302301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
    LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
    Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study.
    Kaiser L; Henry D; Flack NP; Keene O; Hayden FG
    Clin Infect Dis; 2000 Mar; 30(3):587-9. PubMed ID: 10722450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults.
    Boivin G; Goyette N; Hardy I; Aoki F; Wagner A; Trottier S
    J Infect Dis; 2000 Apr; 181(4):1471-4. PubMed ID: 10762579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors.
    Höffken G; Gillissen A
    Med Microbiol Immunol; 2002 Dec; 191(3-4):169-73. PubMed ID: 12458354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.
    Lancet; 1998 Dec; 352(9144):1877-81. PubMed ID: 9863784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza diagnosis and treatment in children: a review of studies on clinically useful tests and antiviral treatment for influenza.
    Uyeki TM
    Pediatr Infect Dis J; 2003 Feb; 22(2):164-77. PubMed ID: 12586981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of inhaled zanamivir in the treatment and prevention of influenza].
    Abad-Santos F; Gallego Sandín S; Novalbos Reina J; Martínez Sancho E; Gálvez Múgica MA
    An Med Interna; 2001 Feb; 18(2):93-9. PubMed ID: 11322008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection.
    Calfee DP; Peng AW; Hussey EK; Lobo M; Hayden FG
    Antivir Ther; 1999; 4(3):143-9. PubMed ID: 12731753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.
    Monto AS; Fleming DM; Henry D; de Groot R; Makela M; Klein T; Elliott M; Keene ON; Man CY
    J Infect Dis; 1999 Aug; 180(2):254-61. PubMed ID: 10395837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial.
    Hedrick JA; Barzilai A; Behre U; Henderson FW; Hammond J; Reilly L; Keene O
    Pediatr Infect Dis J; 2000 May; 19(5):410-7. PubMed ID: 10819336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.
    Matsumoto K; Ogawa N; Nerome K; Numazaki Y; Kawakami Y; Shirato K; Arakawa M; Kudoh S; Shimokata K; Nakajima S; Yamakido M; Kashiwagi S; Nagatake T
    Antivir Ther; 1999; 4(2):61-8. PubMed ID: 10682150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza.
    Ison MG; Gnann JW; Nagy-Agren S; Treannor J; Paya C; Steigbigel R; Elliott M; Weiss HL; Hayden FG;
    Antivir Ther; 2003 Jun; 8(3):183-90. PubMed ID: 12924534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled zanamivir versus placebo for the prevention of influenza outbreaks in an unvaccinated long-term care population.
    Ambrozaitis A; Gravenstein S; van Essen GA; Rubinstein E; Balciuniene L; Stikleryte A; Crawford C; Elliott M; Shult P
    J Am Med Dir Assoc; 2005; 6(6):367-74. PubMed ID: 16286057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zanamivir: an influenza virus neuraminidase inhibitor.
    Colman PM
    Expert Rev Anti Infect Ther; 2005 Apr; 3(2):191-9. PubMed ID: 15918777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial.
    Monto AS; Robinson DP; Herlocher ML; Hinson JM; Elliott MJ; Crisp A
    JAMA; 1999 Jul; 282(1):31-5. PubMed ID: 10404908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.